73.68
price up icon1.28%   0.93
pre-market  Pre-market:  74.51   0.83   +1.13%
loading
Praxis Precision Medicines Inc stock is traded at $73.68, with a volume of 332.55K. It is up +1.28% in the last 24 hours and up +0.66% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
See More
Previous Close:
$72.75
Open:
$72.59
24h Volume:
332.55K
Relative Volume:
1.15
Market Cap:
$1.37B
Revenue:
$1.77M
Net Income/Loss:
$-123.74M
P/E Ratio:
-24.32
EPS:
-3.03
Net Cash Flow:
$-95.21M
1W Performance:
-9.84%
1M Performance:
+0.66%
6M Performance:
+63.70%
1Y Performance:
+5,890%
1-Day Range:
Value
$71.01
$74.68
1-Week Range:
Value
$68.08
$83.88
52-Week Range:
Value
$1.06
$86.93

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
Name
Praxis Precision Medicines Inc
Name
Phone
617-300-8460
Name
Address
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
Employee
82
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PRAX's Discussions on Twitter

Compare PRAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
PRAX 73.68 1.37B 1.77M -123.74M -95.21M -3.03
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-19-23 Initiated Truist Buy
Jun-06-22 Downgrade Wedbush Outperform → Neutral
Dec-16-21 Initiated H.C. Wainwright Buy
Aug-26-21 Initiated BofA Securities Buy
Apr-26-21 Initiated William Blair Outperform
Nov-11-20 Initiated Wedbush Outperform
Nov-10-20 Initiated Cowen Outperform
Nov-10-20 Initiated Evercore ISI Outperform
Nov-10-20 Initiated Piper Sandler Overweight
View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

pulisher
Nov 20, 2024

Why Praxis Precision Medicines Stock Is Trading Higher Tuesday - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down Following Insider Selling - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by CIBC Asset Management Inc - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Alex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Insider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of Stock - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

(PRAX) Proactive Strategies - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 15, 2024

Praxis Precision Medicines principal accounting officer sells $424,318 in stock - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Praxis Precision Medicines principal accounting officer sells $424,318 in stock By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Praxis Precision Medicines' general counsel sells shares worth $660,827 - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9%Should You Sell? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Cormorant Asset Management's Strategic Acquisition in Praxis Pre - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Verition Fund Management LLC Adjusts Stake in Praxis Precision M - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Capital Research Global Investors Acquires New Stake in Praxis P - GuruFocus.com

Nov 13, 2024
pulisher
Nov 11, 2024

Equities Analysts Offer Predictions for PRAX FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Estimate for PRAX Issued By HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024
pulisher
Nov 07, 2024

Praxis Precision Medicines Inc (PRAX) Is Worth A Look Now, Despite -5.10% Loss From High - Stocks Register

Nov 07, 2024
pulisher
Nov 07, 2024

Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... By GuruFocus - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results - citybiz

Nov 07, 2024
pulisher
Nov 07, 2024

Praxis Precision Medicines Reports Q3 2024 Results and Progress - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

Praxis Precision Medicines to Present at Three Major Healthcare Conferences in November | PRAX Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Praxis Precision Advances CNS Disorder Therapies - TipRanks

Nov 06, 2024
pulisher
Nov 06, 2024

Q3 2024 Praxis Precision Medicines Inc Earnings Call Transcript - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial - The Bakersfield Californian

Nov 06, 2024
pulisher
Nov 06, 2024

How the (PRAX) price action is used to our Advantage - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Praxis Precision M - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - The Manila Times

Nov 01, 2024
pulisher
Oct 26, 2024

(PRAX) Trading Advice - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 24, 2024

Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 24, 2024
pulisher
Oct 21, 2024

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 21, 2024
pulisher
Oct 16, 2024

Praxis Precision To Report Aria Study Data In June - RTTNews

Oct 16, 2024
pulisher
Oct 16, 2024

Will Praxis Precision Hit The Targets? - RTTNews

Oct 16, 2024
pulisher
Oct 15, 2024

Praxis Precision Medicines revises executive severance terms - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Where are the Opportunities in (PRAX) - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews

Oct 15, 2024
pulisher
Oct 15, 2024

Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India

Oct 14, 2024
pulisher
Oct 14, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa

Oct 14, 2024

Praxis Precision Medicines Inc Stock (PRAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):